155 related articles for article (PubMed ID: 24878218)
1. C-reactive protein level in morbidly obese patients before and after bariatric surgery.
Rojano-Rodríguez ME; Valenzuela-Salazar C; Cárdenas-Lailson LE; Romero Loera LS; Torres-Olalde M; Moreno-Portillo M
Rev Gastroenterol Mex; 2014; 79(2):90-5. PubMed ID: 24878218
[TBL] [Abstract][Full Text] [Related]
2. Bariatric surgery decreased the serum level of an endotoxin-associated marker: lipopolysaccharide-binding protein.
Yang PJ; Lee WJ; Tseng PH; Lee PH; Lin MT; Yang WS
Surg Obes Relat Dis; 2014; 10(6):1182-7. PubMed ID: 24713521
[TBL] [Abstract][Full Text] [Related]
3. High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery.
Paepegaey AC; Genser L; Bouillot JL; Oppert JM; Clément K; Poitou C
Surg Obes Relat Dis; 2015; 11(1):148-54. PubMed ID: 25393045
[TBL] [Abstract][Full Text] [Related]
4. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
[TBL] [Abstract][Full Text] [Related]
5. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.
Agrawal V; Krause KR; Chengelis DL; Zalesin KC; Rocher LL; McCullough PA
Surg Obes Relat Dis; 2009; 5(1):20-6. PubMed ID: 18951068
[TBL] [Abstract][Full Text] [Related]
6. Serum C-reactive protein and white blood cell count in morbidly obese surgical patients.
Chen SB; Lee YC; Ser KH; Chen JC; Chen SC; Hsieh HF; Lee WJ
Obes Surg; 2009 Apr; 19(4):461-6. PubMed ID: 18651197
[TBL] [Abstract][Full Text] [Related]
7. The effect of weight loss after gastric bypass on C-reactive protein levels.
Zagorski SM; Papa NN; Chung MH
Surg Obes Relat Dis; 2005; 1(2):81-5. PubMed ID: 16925219
[TBL] [Abstract][Full Text] [Related]
8. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
9. Changes in high-sensitivity C-reactive protein levels after laparoscopic gastric stapling procedures versus laparoscopic gastric banding.
Gebhart A; Young M; Villamere J; Shih A; Nguyen NT
Am Surg; 2014 Oct; 80(10):1044-8. PubMed ID: 25264657
[TBL] [Abstract][Full Text] [Related]
10. Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index?
Luconi M; Samavat J; Seghieri G; Iannuzzi G; Lucchese M; Rotella C; Forti G; Maggi M; Mannucci E
Fertil Steril; 2013 Jun; 99(7):1872-9.e1. PubMed ID: 23507475
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.
Khaodhiar L; Ling PR; Blackburn GL; Bistrian BR
JPEN J Parenter Enteral Nutr; 2004; 28(6):410-5. PubMed ID: 15568287
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of axial back pain symptoms before and after bariatric weight reduction surgery.
Khoueir P; Black MH; Crookes PF; Kaufman HS; Katkhouda N; Wang MY
Spine J; 2009 Jun; 9(6):454-63. PubMed ID: 19356988
[TBL] [Abstract][Full Text] [Related]
13. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy.
Carbone F; Nulli Migliola E; Bonaventura A; Vecchié A; De Vuono S; Ricci MA; Vaudo G; Boni M; Dallegri F; Montecucco F; Lupattelli G
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):494-500. PubMed ID: 29502925
[TBL] [Abstract][Full Text] [Related]
14. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
Nestvold TK; Nielsen EW; Lappegård KT
Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
[TBL] [Abstract][Full Text] [Related]
16. Fasting glycemia: a good predictor of weight loss after RYGB.
Faria G; Preto J; Almeida AB; Guimarães JT; Calhau C; Taveira-Gomes A
Surg Obes Relat Dis; 2014; 10(3):419-24. PubMed ID: 24462312
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide production is paradoxically decreased after weight reduction surgery in morbid obesity patients.
Lin LY; Lee WJ; Shen HN; Yang WS; Pai NH; Su TC; Liau CS
Atherosclerosis; 2007 Feb; 190(2):436-42. PubMed ID: 16546195
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
[TBL] [Abstract][Full Text] [Related]
20. Influence of obesity and surgical weight loss on thyroid hormone levels.
Chikunguwo S; Brethauer S; Nirujogi V; Pitt T; Udomsawaengsup S; Chand B; Schauer P
Surg Obes Relat Dis; 2007; 3(6):631-5; discussion 635-6. PubMed ID: 18023816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
